Probe based qPCR assay complete solution

Integrated DNA Technologies (IDT) has introduced its latest addition to an expanding genomic applications portfolio: PrimeTime® Gene Expression Master Mix, an optimized enzyme mix for probe-based qPCR. IDT continues to provide higher value qPCR products by delivering superior assay performance at a lower price per reaction, while empowering customers with access to assay sequences.

Singleplex and duplex PrimeTime® qPCR Assays using the PrimeTime Master Mix

This newest product enhances the IDT PrimeTime qPCR product line, as researchers can economically obtain both assays and a master mix that are optimized and validated to work together.

PrimeTime qPCR Assays are available with a choice of dyes and quenchers, and the predesigned assays are backed by a performance guarantee. The versatile, stable Master Mix easily integrates into new and existing experimental workflows, because it is also compatible with all commercially available 5’ nuclease gene expression assays.

The PrimeTime qPCR Assays and Master Mix deliver accurate, sensitive gene expression analysis with efficiencies >90% in two-step RT-qPCR under both fast and standard cycling conditions.

This provides the reproducibility that gives researchers confidence in the quality of their data, whether it be from singleplex or duplex reactions.

As highlighted by Sandy Junek, Molecular Lab Manager at Discovery Seed Labs, Canada, “The PrimeTime Gene Expression Master Mix worked very well for us. I was able to use it effectively in a two-target multiplex reaction, with no difference in amplification of the targets compared to the singleplex reactions.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Integrated DNA Technologies. (2019, June 18). Probe based qPCR assay complete solution. News-Medical. Retrieved on November 24, 2024 from https://www.news-medical.net/news/20151210/Probe-based-qPCR-assay-complete-solution.aspx.

  • MLA

    Integrated DNA Technologies. "Probe based qPCR assay complete solution". News-Medical. 24 November 2024. <https://www.news-medical.net/news/20151210/Probe-based-qPCR-assay-complete-solution.aspx>.

  • Chicago

    Integrated DNA Technologies. "Probe based qPCR assay complete solution". News-Medical. https://www.news-medical.net/news/20151210/Probe-based-qPCR-assay-complete-solution.aspx. (accessed November 24, 2024).

  • Harvard

    Integrated DNA Technologies. 2019. Probe based qPCR assay complete solution. News-Medical, viewed 24 November 2024, https://www.news-medical.net/news/20151210/Probe-based-qPCR-assay-complete-solution.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
IDT partners with iGEM to support young researchers and promote scientific progress